Jaguar Health (JAGX) Shares Up 5.9%

Shares of Jaguar Health Inc (NASDAQ:JAGX) shot up 5.9% during mid-day trading on Wednesday . The stock traded as high as $0.19 and last traded at $0.18. 5,682,818 shares traded hands during mid-day trading, an increase of 7% from the average session volume of 5,293,302 shares. The stock had previously closed at $0.17.

Several research firms recently commented on JAGX. ValuEngine lowered Jaguar Health from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. HC Wainwright reissued a “buy” rating on shares of Jaguar Health in a report on Monday, April 15th.

The company has a quick ratio of 0.18, a current ratio of 0.30 and a debt-to-equity ratio of 0.02.

ILLEGAL ACTIVITY WARNING: This story was first reported by Rockland Register and is the property of of Rockland Register. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://rocklandregister.com/2019/05/31/jaguar-health-jagx-shares-up-5-9.html.

Jaguar Health Company Profile (NASDAQ:JAGX)

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

See Also: Systematic Risk

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.